1. Amesite launched NurseMagic™ EMR, expanding its technology platform significantly. 2. Company reported sequential revenue growth with 2.4x increase post-Teams+ launch. 3. The U.S. post-acute care market is projected to exceed $850 billion. 4. Increasing website traffic indicates growing interest in deployable AI solutions. 5. NurseMagic™ serves diverse post-acute care providers, enhancing market positioning.
FAQ
Why Bullish?
The launch of NurseMagic™ EMR enhances Amesite's market position, likely boosting revenue and investor confidence.
How important is it?
The expansion into EMR signifies critical growth potential, aligning product offerings with market needs.
Why Short Term?
Immediate onboarding of EMR customers expected in January 2026 will rapidly influence short-term revenue growth.
Amesite Accelerates Growth With Launch of AI-Native NurseMagic™ EMR
DETROIT, Dec. 19, 2025 (GLOBE NEWSWIRE) – Amesite Inc. (NASDAQ: AMST) has announced the launch of its innovative NurseMagic™ EMR, a strategic expansion of the Company’s technology platform. The release follows a year marked by strong sequential revenue growth and heightened enterprise adoption. This AI-native, modular electronic medical record (EMR) solution transitions NurseMagic™ from a point-of-care tool to an essential component of post-acute care infrastructure, permitting integration with existing legacy systems or complete system replacement.
NurseMagic™ EMR Launch Details
Amesite plans to commence onboarding customers for the NurseMagic™ EMR in January 2026. The Company’s revenue trajectory has significantly increased alongside the introduction of higher-value product tiers, evolving from individual solutions to Teams, Teams+, and Enterprise offerings. Notably, following the launch of Teams+ in May 2025, Amesite reported a remarkable 2.4x increase in quarterly revenue. The introduction of the Enterprise tier in July 2025, which is priced based on patient census rather than individual users, led to an 82% revenue increase in the fourth quarter. The ongoing expansion of its Enterprise capabilities has spurred a further 69% quarter-over-quarter revenue growth in the first quarter of fiscal 2026.
Market Insights
The U.S. post-acute care market ranks among the fastest-growing healthcare sectors, valued at over $470 billion in 2024 and projected to surpass $850 billion in the coming years. This growth is propelled by factors such as an aging population, an escalating burden of chronic diseases, and a shift towards cost-effective, home-based care models. Technology-enabled solutions like NurseMagic™ are proving effective in driving down costs while enhancing clinical outcomes.
Strategic Advantages of NurseMagic™ EMR
Brandon Owens, VP of Sales at Amesite, emphasized the flexibility of the new NurseMagic™ EMR, stating, “What makes this launch particularly powerful from a sales perspective is the flexibility it gives our customers. We can work alongside existing EMRs, delivering immediate operational and financial impact without disruption, or we can replace them entirely with a full AI-native EMR built for how post-acute care operates today.” This adaptability enables clients to choose between incremental improvements and comprehensive changes.
Growing Demand for AI Solutions
As of January 2025, visits to Amesite's website have surged nearly 1,400%, signaling a rising interest in deployable AI solutions within the post-acute care sector. Madison Bush, Director of Corporate Operations at Amesite, noted that the expansion of NurseMagic™'s capabilities has translated to increased engagement on digital platforms, indicating solid momentum leading up to the NurseMagic™ EMR launch.
Future Outlook
Dr. Ann Marie Sastry, CEO and Founder of Amesite, remarked, “Reaching this stage reflects the disciplined way we have built NurseMagic™. With an AI-native EMR, demonstrated enterprise adoption, and a pricing model aligned with patient volumes, we are extending our platform into the core systems that post-acute care organizations depend on.” This launch signifies a crucial advancement in Amesite’s long-term strategy to provide infrastructure-level solutions tailored to customer needs.
About Amesite Inc.
Amesite (NASDAQ: AMST) is an AI-driven software company dedicated to delivering advanced technology platform solutions. The NurseMagic™ product suite aims to streamline clinical documentation and support decision-making at the point of care. The platform caters to over 100 professions across all 50 U.S. states and more than 20 countries, built on proprietary AI technology and compliant with necessary regulatory and security standards.